ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 2137

Linear Extrapolation of Missing Radiographic Progression Scores Does Not Spuriously overestimate overall Radiographic Progression in Rheumatoid Arthritis

Iris Markusse1, Robert Landewé2,3, Meilien Ho4, Martin Jenkins4 and Desiree van der Heijde5, 1Leiden University Medical Center, Leiden, Netherlands, 2Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 3Atrium Medical Center, Heerlen, Netherlands, 4AstraZeneca R&D Alderley Park, Macclesfield, United Kingdom, 5Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Missing data, multiple imputation, radiography and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Session Title: Imaging of Rheumatic Diseases: Various Imaging Techniques

Session Type: Abstract Submissions (ACR)

Background/Purpose : Linear Extrapolation (LE) is a frequently applied method to impute missing radiographic data in trials. However, there is frequent critique that LE overestimates overall progression. Therefore, ‘Last Observation Carried Forward’ (LOCF) has been suggested by regulatory bodies as a more conservative method. In the OSKIRA-1 trial (NCT01197521), radiographs were taken at the 12 week (wk) time point, where early escape was possible, in all patients thus providing an excellent opportunity to compare extrapolations based upon LOCF and LE to the truly observed radiographic progression.

Methods : The phase 3 OSKIRA-1 trial enrolled rheumatoid arthritis patients (pts) with an inadequate response to methotrexate. Films of hands and feet were obtained at baseline, wk 12 and 24 in those pts still on study, and were assessed by two readers in random time order using the van der Heijde modified total Sharp score (mTSS). Ten datasets with an artificially, randomly selected sample of 20% missing wk 24 data were created, based upon pts with complete sets of films. First, these missing data were imputed using LE as (mTSS at wk 12 + progression wk 0 – 12, corrected for the actual days between films). Second, the missing data were imputed using LOCF. This approach was iterated for 10 random samples with 50% missing data and 10 random samples with 80% missing data. The datasets obtained with LE and LOCF were compared to the dataset with truly observed data at week 24.

Results : Complete sets of films were available for 579 pts. All our analyses were essentially similar in the 3 treatment arms, so here we present the analysis on pooled data. Mean (SD) observed progression from baseline to wk 24 was 0.33 (2.42). Table 1 shows the average (SD) and range of the mean radiographic progression in the 10 random samples. Using LE, the mean progression estimates were close to the observed data, and not affected by the proportion of missing data. The SD however increased by increasing proportions of missing data. Using LOCF, the mean progression estimates were consistently lower than the observed progression. LOCF increasingly underestimated observed progression by increasing proportions of missing data. As expected, the SD of the LOCF estimates remained stable by increasing proportions of missing data.  

Conclusion : In contrast to LOCF, linear extrapolation gives a more accurate impression of true mean radiographic progression at a group level and is less influenced by the proportion of missing data. Since LE inflates the standard deviation of progression scores, the statistical power to detect a significant difference between active treatment and placebo may decrease by increasing proportions of missingness. LE does therefore not overestimate mean treatment effects and is a more robust method than LOCF in this respect.

Table 1: Change in the van der Heijde modified total Sharp score (mTSS) from baseline to week 24.

 

Observed change in mTSS in patients completing 24 weeks, mean (SD): 0.33 (2.42)

Method

Mean of the mean*

Mean of the SD*

Minimum mean*

Maximum mean*

Minimum SD*

Maximum SD*

20% missing data

LOCF

0.29

2.43

0.28

0.32

2.38

2.48

LE

0.32

3.02

0.27

0.39

2.60

4.44

50% missing data

LOCF

0.25

2.41

0.21

0.29

2.32

2.49

LE

0.34

3.83

0.22

0.42

2.73

4.61

80% missing data

LOCF

0.19

2.41

0.18

0.21

2.37

2.44

LE

0.30

4.19

0.21

0.36

3.05

4.74

*of 10 random samples

LE, linear extrapolation; LOCF, last observation carried forward; mTSS, van der Heijde modified total Sharp score; SD, standard deviation.


Disclosure:

I. Markusse,
None;

R. Landewé,

Rheumatology Consulting BV,

9;

M. Ho,

AstraZeneca,

3,

AstraZeneca,

1;

M. Jenkins,

AstraZeneca,

3,

AstraZeneca,

1;

D. van der Heijde,

AstraZeneca,

9,

Imaging Rheumatology BV,

9.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/linear-extrapolation-of-missing-radiographic-progression-scores-does-not-spuriously-overestimate-overall-radiographic-progression-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies